Why the study?
The study aimed to assess the association between high-sensitivity C-reactive protein-to-albumin ratio (CAR) and in-hospital MACE in ACS patients, and whether it outperforms hsCRP or albumin alone.
Does a high sensitivity-C reactive protein to albumin ratio (CAR) predict in-hospital MACE in patients with acute coronary syndrome?
Does a high sensitivity-C reactive protein to albumin ratio (CAR) predict in-hospital MACE in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
The high sensitivity-C reactive protein to albumin ratio at presentation may serve as a useful biomarker to predict in-hospital adverse events in patients with acute coronary syndrome.
Objective: Our study aimed to determine the association between high sensitivity-c reactive protein to albumin ratio (CAR) and in-hospital major adverse cardiovascular event (MACE) in patients with acute coronary syndrome and also to assess whether hs-CAR is a better marker than hsCRP or albumin alone in predicting MACE. Materials and Methods: We enrolled 110 cases who were hospitalized and major adverse cardiovascular event was defined as cardiogenic shock, acute heart failure, reinfarction and death. Blood sample for Serum albumin and hs-crp was taken at the time when patients were admitted. Results: The incidence of MACE was more in patients with high CAR (≥1.8 group) as compared to those with low CAR (<1.8 group). Conclusion: The CAR is an independent predictor of MACE in patients who present with ACS.
No takes yet. Share an insight, caveat, or question.
Mir et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: